{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:28:24Z","timestamp":1790760504479,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fungal Genetics and Biology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.fgb.2019.103243","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T04:02:21Z","timestamp":1561003341000},"page":"103243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":208,"special_numbering":"C","title":["Candida auris and multidrug resistance: Defining the new normal"],"prefix":"10.1016","volume":"131","author":[{"given":"Shawn R.","family":"Lockhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fgb.2019.103243_b0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/myc.12886","article-title":"Candida auris otomycosis in Iran and review of recent literature","volume":"62","author":"Abastabar","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103243_b0010","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3201\/eid2410.180649","article-title":"Candida auris in healthcare facilities, New York, USA, 2013\u20132017","volume":"24","author":"Adams","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103243_b0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/myc.12907","article-title":"A high-throughput and rapid method for accurate identification of emerging multidrug-resistant Candida auris","volume":"62","author":"Ahmad","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103243_b0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/myc.12709","article-title":"Isolation of Candida auris from 9 patients in Central America: importance of accurate diagnosis and susceptibility testing","volume":"61","author":"Arauz","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103243_b0025","doi-asserted-by":"crossref","first-page":"e01225","DOI":"10.1128\/AAC.01225-18","article-title":"APX001A in vitro activity against contemporary blood isolates and Candida auris determined by the EUCAST reference method","volume":"62","author":"Arendrup","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0030","doi-asserted-by":"crossref","first-page":"e00485","DOI":"10.1128\/AAC.00485-17","article-title":"Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values","volume":"61","author":"Arendrup","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0035","doi-asserted-by":"crossref","DOI":"10.3201\/eid2302.161486","article-title":"Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv, Israel","volume":"23","author":"Ben-Ami","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103243_b0040","doi-asserted-by":"crossref","first-page":"e00435","DOI":"10.1128\/AAC.00435-17","article-title":"In vitro activity of a novel glucan synthase inhibitor, SCY-078, against clinical Isolates of Candida auris","volume":"61","author":"Berkow","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.fgb.2019.103243_b0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.diagmicrobio.2017.10.021","article-title":"Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris","volume":"90","author":"Berkow","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103243_b0055","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1093\/jac\/dky302","article-title":"Activity of novel antifungal compound APX001A against a large collection of Candida auris","volume":"73","author":"Berkow","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0060","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1038\/s41598-019-41513-6","article-title":"Gene duplication associated with increased fluconazole tolerance in Candida auris cells of advanced generational age","volume":"9","author":"Bhattacharya","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fgb.2019.103243_b0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jinf.2016.07.008","article-title":"First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia","volume":"73","author":"Calvo","year":"2016","journal-title":"J. Infect."},{"key":"10.1016\/j.fgb.2019.103243_b0070","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/JCM.02248-12","article-title":"Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts","volume":"50","author":"Cendejas-Bueno","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0075","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/AAC.00095-07","article-title":"Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences","volume":"51","author":"Chamilos","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0080","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10096-013-2027-1","article-title":"Multidrug-resistant endemic clonal strain of Candida auris in India","volume":"33","author":"Chowdhary","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103243_b0085","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jac\/dkx480","article-title":"A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009\u201317) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance","volume":"73","author":"Chowdhary","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0090","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3201\/eid1910.130393","article-title":"New clonal strain of Candida auris, Delhi, India","volume":"19","author":"Chowdhary","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103243_b0095","doi-asserted-by":"crossref","first-page":"e1006290","DOI":"10.1371\/journal.ppat.1006290","article-title":"Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally","volume":"13","author":"Chowdhary","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.fgb.2019.103243_b0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhin.2016.08.004","article-title":"Multidrug-resistant Candida auris: 'new kid on the block' in hospital-associated infections?","volume":"94","author":"Chowdhary","year":"2016","journal-title":"J. Hosp. Infect."},{"issue":"Suppl 1","key":"10.1016\/j.fgb.2019.103243_b0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","article-title":"Amphotericin B: spectrum and resistance","volume":"49","author":"Ellis","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.15585\/mmwr.mm6715a6","article-title":"Notes from the field: surveillance for Candida auris - Colombia, September 2016-May 2017","volume":"67","author":"Escandon","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.fgb.2019.103243_b0115","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/AAC.01519-13","article-title":"Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0125","doi-asserted-by":"crossref","first-page":"e02319","DOI":"10.1128\/AAC.02319-17","article-title":"In vitro and in vivo evaluation of the antifungal activity of APX001A\/APX001 against Candida auris","volume":"62","author":"Hager","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0130","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/jac\/dky153","article-title":"Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model","volume":"73","author":"Hager","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0135","doi-asserted-by":"crossref","first-page":"e01427","DOI":"10.1128\/AAC.01427-18","article-title":"Limited ERG11 mutations identified in isolates of Candida auris directly contribute to reduced azole susceptibility","volume":"62","author":"Healey","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0140","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1177\/0091270005279580","article-title":"Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction","volume":"45","author":"Hebert","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.fgb.2019.103243_b0145","first-page":"e01811","article-title":"Rapid detection of ERG11-associated azole resistance and FKS-associated echinocandin resistance in Candida auris","volume":"63","author":"Hou","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0150","unstructured":"Clinical and Laboratory Standards Institute, Principles and procedures for the development of epidemiological cutoff values for antifungal susceptibility testing 1st ed. CLSI guide M57. Clinical and Laboratory Standards Institute, Wayne, PA, 2016."},{"key":"10.1016\/j.fgb.2019.103243_b0155","doi-asserted-by":"crossref","first-page":"e00029","DOI":"10.1128\/CMR.00029-17","article-title":"Candida auris: a review of the literature","volume":"31","author":"Jeffery-Smith","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.fgb.2019.103243_b0160","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/JCM.00367-15","volume":"53","author":"Kathuria","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0165","doi-asserted-by":"crossref","first-page":"e00334","DOI":"10.1128\/mSphere.00334-18","article-title":"Transcriptome assembly and profiling of Candida auris reveals novel insights into biofilm-mediated resistance","volume":"3","author":"Kean","year":"2018","journal-title":"mSphere."},{"key":"10.1016\/j.fgb.2019.103243_b0170","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1086\/597108","article-title":"Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features","volume":"48","author":"Kim","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103243_b0175","doi-asserted-by":"crossref","first-page":"e00238","DOI":"10.1128\/AAC.00238-18","article-title":"Understanding echinocandin resistance in the emerging pathogen Candida auris","volume":"62","author":"Kordalewska","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0180","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3855\/jidc.4582","article-title":"Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis","volume":"9","author":"Kumar","year":"2015","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.fgb.2019.103243_b0185","doi-asserted-by":"crossref","first-page":"e01624","DOI":"10.1128\/JCM.01624-18","article-title":"Candida auris clinical Isolates from South Korea: identification, antifungal susceptibility, and genotyping","volume":"57","author":"Kwon","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0190","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0195","doi-asserted-by":"crossref","first-page":"e02396","DOI":"10.1128\/AAC.02396-16","article-title":"The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation","volume":"61","author":"Larkin","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0200","doi-asserted-by":"crossref","first-page":"e01223","DOI":"10.1128\/JCM.01223-17","article-title":"Development and validation of a real-time PCR Assay for rapid detection of Candida auris from surveillance samples","volume":"56","author":"Leach","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0205","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1128\/JCM.00319-11","article-title":"First three reported cases of nosocomial fungemia caused by Candida auris","volume":"49","author":"Lee","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0210","doi-asserted-by":"crossref","first-page":"e01572","DOI":"10.1128\/AAC.01572-18","article-title":"Pharmacodynamic evaluation of rezafungin (CD101) against Candida auris in the neutropenic mouse invasive candidiasis model","volume":"62","author":"Lepak","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0215","doi-asserted-by":"crossref","first-page":"e00791","DOI":"10.1128\/AAC.00791-17","article-title":"Pharmacodynamic optimization for treatment of invasive Candida auris infection","volume":"61","author":"Lepak","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clinmicnews.2017.06.003","article-title":"Candida auris for the clinical microbiology laboratory: not your grandfather's Candida species","volume":"39","author":"Lockhart","year":"2017","journal-title":"Clin. Microbiol. Newsl."},{"key":"10.1016\/j.fgb.2019.103243_b0225","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103243_b0230","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","article-title":"Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011","volume":"50","author":"Lockhart","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0235","doi-asserted-by":"crossref","DOI":"10.1111\/myc.12904","article-title":"Candida auris - the growing menace to global health","author":"Lone","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103243_b0240","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3201\/eid2007.131765","article-title":"Candida auris-associated candidemia, South Africa","volume":"20","author":"Magobo","year":"2014","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.fgb.2019.103243_b0245","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/myc.12834","article-title":"Internal validation of GPS(\u202f) MONODOSE CanAur dtec-qPCR kit following the UNE\/EN ISO\/IEC 17025:2005 for detection of the emerging yeast Candida auris","volume":"61","author":"Martinez-Murcia","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103243_b0250","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/myc.12790","article-title":"Five-year profile of candidaemia at an Indian trauma centre: high rates of Candida auris blood stream infections","volume":"61","author":"Mathur","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103243_b0255","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3201\/eid2301.161497","article-title":"Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia","volume":"23","author":"Morales-Lopez","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103243_b0260","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1038\/s41467-018-07779-6","article-title":"Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species","volume":"9","author":"Munoz","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fgb.2019.103243_b0265","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/AAC.45.10.2676-2684.2001","article-title":"Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients","volume":"45","author":"Perea","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12831","article-title":"Mechanisms of echinocandin antifungal drug resistance","volume":"1354","author":"Perlin","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.fgb.2019.103243_b0275","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.fgb.2019.103243_b0280","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cmi.2015.10.022","article-title":"Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism","volume":"22","author":"Prakash","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.fgb.2019.103243_b0285","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00371-18","article-title":"Emerging multidrug-resistant Candida duobushaemulonii infections in Panama hospitals: importance of laboratory surveillance and accurate identification","author":"Ramos","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0290","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mib.2018.02.005","article-title":"Antifungal drug resistance: evolution, mechanisms and impact","volume":"45","author":"Revie","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0295","first-page":"43","article-title":"Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris","volume":"7","author":"Rhodes","year":"2018","journal-title":"Emerg. Microbes. Infect."},{"key":"10.1016\/j.fgb.2019.103243_b0300","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","article-title":"Molecular evolution of antifungal drug resistance","volume":"71","author":"Robbins","year":"2017","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0305","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jac\/dkx034","article-title":"Candida auris candidaemia in Indian ICUs: analysis of risk factors","volume":"72","author":"Rudramurthy","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0310","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/myc.12781","article-title":"An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital","volume":"61","author":"Ruiz-Gaitan","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103243_b0315","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijantimicag.2019.02.005","article-title":"Outbreak of Candida auris in Spain: a comparison of antifungal activity by three methods with published data","volume":"53","author":"Ruiz-Gaitan","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.fgb.2019.103243_b0320","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.riam.2016.11.002","article-title":"Nosocomial fungemia by Candida auris: first four reported cases in continental Europe","volume":"34","author":"Ruiz Gaitan","year":"2017","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.fgb.2019.103243_b0325","doi-asserted-by":"crossref","first-page":"e00057","DOI":"10.1128\/AAC.00057-19","article-title":"Abrogation of triazole resistance upon deletion of CDR1 in a clinical Isolate of Candida auris","volume":"63","author":"Rybak","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0330","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/AAC.42.5.1057","article-title":"In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts","volume":"42","author":"Ryder","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0335","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.fgb.2019.103243_b0340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","article-title":"First hospital outbreak of the globally emerging Candida auris in a European hospital","volume":"5","author":"Schelenz","year":"2016","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"10.1016\/j.fgb.2019.103243_b0345","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.1128242","article-title":"Aneuploidy and isochromosome formation in drug-resistant Candida albicans","volume":"313","author":"Selmecki","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.fgb.2019.103243_b0350","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/myc.12817","article-title":"Evaluation of a new T2 magnetic resonance assay for rapid detection of emergent fungal pathogen Candida auris on clinical skin swab samples","volume":"61","author":"Sexton","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.fgb.2019.103243_b0355","doi-asserted-by":"crossref","first-page":"e01337","DOI":"10.1128\/JCM.01337-18","article-title":"Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR green-based quantitative PCR assay","volume":"56","author":"Sexton","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0360","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nmni.2016.07.003","article-title":"Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation","volume":"13","author":"Sharma","year":"2016","journal-title":"New Microbes. New Infect."},{"key":"10.1016\/j.fgb.2019.103243_b0365","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1128\/JCM.06440-11","article-title":"Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods","volume":"50","author":"Shin","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0370","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/AAC.00880-07","article-title":"In vitro study of Candida tropicalis isolates exhibiting paradoxical growth in the presence of high concentrations of caspofungin","volume":"51","author":"Soczo","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0375","doi-asserted-by":"crossref","first-page":"514","DOI":"10.15585\/mmwr.mm6619a7","article-title":"Notes from the field: ongoing transmission of Candida auris in health care facilities - United States, June 2016-May 2017","volume":"66","author":"Tsay","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.fgb.2019.103243_b0380","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1469-0691.2006.01377.x","article-title":"Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values","volume":"12","author":"Turnidge","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.fgb.2019.103243_b0385","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.15585\/mmwr.mm6544e1","article-title":"Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus - United States, May 2013-August 2016","volume":"65","author":"Vallabhaneni","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.fgb.2019.103243_b0390","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fcimb.2019.00020","article-title":"Candida auris identification and rapid antifungal susceptibility testing against echinocandins by MALDI-TOF MS","volume":"9","author":"Vatanshenassan","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.fgb.2019.103243_b0395","doi-asserted-by":"crossref","first-page":"e1001692","DOI":"10.1371\/journal.pbio.1001692","article-title":"Fitness trade-offs restrict the evolution of resistance to amphotericin B","volume":"11","author":"Vincent","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.fgb.2019.103243_b0400","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1128\/AAC.39.11.2520","article-title":"Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates","volume":"39","author":"Wanger","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0405","doi-asserted-by":"crossref","first-page":"e02233","DOI":"10.1128\/AAC.02233-18","article-title":"The fungal Cyp51-specific inhibitor VT-1598 demonstrates in vitro and in vivo activity against Candida auris","volume":"63","author":"Wiederhold","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2019.103243_b0410","first-page":"e02542","article-title":"In vivo pharmacokinetics and pharmacodynamics of APX001 against Candida spp. in a neutropenic disseminated candidiasis mouse model","volume":"62","author":"Zhao","year":"2018","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Fungal Genetics and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087184519301501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087184519301501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:43:06Z","timestamp":1761068586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087184519301501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":82,"alternative-id":["S1087184519301501"],"URL":"https:\/\/doi.org\/10.1016\/j.fgb.2019.103243","relation":{},"ISSN":["1087-1845"],"issn-type":[{"value":"1087-1845","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candida auris and multidrug resistance: Defining the new normal","name":"articletitle","label":"Article Title"},{"value":"Fungal Genetics and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fgb.2019.103243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103243"}}